Equinor ASA vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Equinor ASA trades at $45.13 (market cap $107.46B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Equinor ASA is far larger — about 10.1× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Equinor ASA pays the higher dividend (3.44%). Which is the better fit depends on your goals — on Pluang, investors hold Equinor ASA for 59 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| EQNR | RDY | |
|---|---|---|
Market Cap | $107.46B | $10.61B |
Volume | 3,758,208 | 3,738,869 |
Sector | Energy | Health |
52-Week High | $45.75 | $15.38 |
52-Week Low | $22.41 | $11.38 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $116.16B | $10.51B |
Dividend Yield | 3.44% | 0.65% |
Signals from Pluang's Aura AI — not financial advice
Equinor (EQNR) trades at $45.02, up 2.46% today and near its 52-week high of $45.84. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates in three of the last four quarters. Recent news highlights expansion in LNG operations and carbon capture projects, while financials show solid profitability with 21.32% ROE and attractive valuation metrics including a 12.27 P/E ratio.
EQNR presents a compelling value opportunity with significant upside to the $87.50 consensus price target. However, investors face risks from volatile energy prices and declining profit margins, though the company's strategic LNG expansion and share buyback program provide support. The mixed analyst sentiment (30% Buy, 57% Hold) suggests cautious optimism amid energy sector uncertainties.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →